Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Schulz

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Endocrine-Related Cancer|September 7, 2006
Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinomaS Fritzsche, M Kenzelmann, M J Hoffmann, et al.
British Journal of Cancer|March 4, 1998
Frequent and heterogeneous expression of cyclin-dependent kinase inhibitor WAF1/p21 protein and mRNA in urothelial carcinomaS Clasen, W A Schulz, C D Gerharz, et al.
Mutation Research|June 19, 2001
Polymorphic methyl group metabolism genes in patients with transitional cell carcinoma of the urinary bladderF Kimura, A R Florl, C Steinhoff, et al.
Molecular Carcinogenesis|September 25, 2001
Hypermethylation of the tumor necrosis factor receptor superfamily 6 (APT1, Fas, CD95/Apo-1) gene promoter at rel/nuclear factor kappaB sites in prostatic carcinomaS Santourlidis, U Warskulat, A R Florl, et al.
Cancer Research|March 1, 1994
Lowered amounts of the tissue-specific transcription factor LFB1 (HNF1) correlate with decreased levels of glutathione S-transferase alpha messenger RNA in human renal cell carcinomaA Clairmont, T Ebert, H Weber, et al.
The Prostate|November 14, 2000
Methyl group metabolism gene polymorphisms and susceptibility to prostatic carcinomaF Kimura, K H Franke, C Steinhoff, et al.
British Journal of Cancer|December 19, 2001
Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladderF Kimura, A R Florl, H H Seifert, et al.
International Journal of Oncology|September 10, 2003
The androgen receptor in hormone-refractory prostate cancer: relevance of different mechanisms of androgen receptor signaling (Review)M V Cronauer, W A Schulz, T Burchardt, et al.
Cancer Research|September 2, 2000
Delineation of the 6p22 amplification unit in urinary bladder carcinoma cell linesJ Bruch, W A Schulz, J Häussler, et al.
British Journal of Cancer|August 5, 2004
Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylationA R Florl, C Steinhoff, M Müller, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Endocrine-Related Cancer|September 7, 2006
Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinomaS Fritzsche, M Kenzelmann, M J Hoffmann, et al.
British Journal of Cancer|March 4, 1998
Frequent and heterogeneous expression of cyclin-dependent kinase inhibitor WAF1/p21 protein and mRNA in urothelial carcinomaS Clasen, W A Schulz, C D Gerharz, et al.
Mutation Research|June 19, 2001
Polymorphic methyl group metabolism genes in patients with transitional cell carcinoma of the urinary bladderF Kimura, A R Florl, C Steinhoff, et al.
Molecular Carcinogenesis|September 25, 2001
Hypermethylation of the tumor necrosis factor receptor superfamily 6 (APT1, Fas, CD95/Apo-1) gene promoter at rel/nuclear factor kappaB sites in prostatic carcinomaS Santourlidis, U Warskulat, A R Florl, et al.
Cancer Research|March 1, 1994
Lowered amounts of the tissue-specific transcription factor LFB1 (HNF1) correlate with decreased levels of glutathione S-transferase alpha messenger RNA in human renal cell carcinomaA Clairmont, T Ebert, H Weber, et al.
The Prostate|November 14, 2000
Methyl group metabolism gene polymorphisms and susceptibility to prostatic carcinomaF Kimura, K H Franke, C Steinhoff, et al.
British Journal of Cancer|December 19, 2001
Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladderF Kimura, A R Florl, H H Seifert, et al.
International Journal of Oncology|September 10, 2003
The androgen receptor in hormone-refractory prostate cancer: relevance of different mechanisms of androgen receptor signaling (Review)M V Cronauer, W A Schulz, T Burchardt, et al.
Cancer Research|September 2, 2000
Delineation of the 6p22 amplification unit in urinary bladder carcinoma cell linesJ Bruch, W A Schulz, J Häussler, et al.
British Journal of Cancer|August 5, 2004
Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylationA R Florl, C Steinhoff, M Müller, et al.
Pageof 9